anileridine phosphate

anileridine phosphate (LERITINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

LERITINE is a marketed brand name for anileridine phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

anileridine phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.